首页> 外文期刊>European Heart Journal: The Journal of the European Society of Cardiology >Tackling Heart Failure in Africa via innovative research: Setting the agenda
【24h】

Tackling Heart Failure in Africa via innovative research: Setting the agenda

机译:通过创新研究解决非洲心力衰竭:制定议程

获取原文
获取原文并翻译 | 示例
           

摘要

TAR DNA-binding protein (TDP-43) pathology and reduced expression of adenosine deaminase acting on RNA 2 (ADAR2), which is the RNA editing enzyme responsible for adenosine-to-inosine conversion at the GluA2 glutamine/arginine (Q/R) site, concomitantly occur in the same motor neurons of amyotrophic lateral sclerosis (ALS) patients; this finding suggests a link between these two ALS-specific molecular abnormalities. AMPA receptors containing Q/R site-unedited GluA2 in their subunit assembly are Ca2+-permeable, and motor neurons lacking ADAR2 undergo slow death in conditional ADAR2 knockout (AR2) mice, which is a mechanistic ALS model in which the ADAR2 gene is targeted in cholinergic neurons. Moreover, deficient ADAR2 induced mislocalization of TDP-43 similar to TDP-43 pathology seen in the sporadic ALS patients in the motor neurons of AR2 mice. The abnormal mislocalization of TDP-43 specifically resulted from activation of the Ca2+-dependent serine protease calpain that specifically cleaved TDP-43 at the C-terminal region, and generated aggregation-prone N-terminal fragments. Notably, the N-terminal fragments of TDP-43 lacking the C-terminus were demonstrated in the brains and spinal cords of ALS patients. Because normalization of either the Ca2+-permeability of AMPA receptors or the calpain activity in the motor neurons normalized the subcellular localization of TDP-43 in AR2 mice, it is likely that exaggerated calpain-dependent TDP-43 fragments played a role at least in the initiation of TDP-43 pathology. Elucidation of the molecular cascade of neuronal death induced by ADAR2 downregulation could provide a new specific therapy for sporadic ALS. In this review, we summarized the work from our group on the role of inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in sporadic ALS, and discussed possible effects of inefficient ADAR2-mediated RNA editing in general. This article is part of a Special Issue entitled RNA Metabolism 2013.
机译:TAR DNA结合蛋白(TDP-43)病理学和作用于RNA 2(ADAR2)的腺苷脱氨酶表达降低,RNA 2是负责在GluA2谷氨酰胺/精氨酸(Q / R)进行腺苷至肌苷转化的RNA编辑酶肌萎缩性侧索硬化症(ALS)患者的同一运动神经元中同时发生该部位;这一发现表明这两种ALS特异性分子异常之间存在联系。在其亚基装配中含有Q / R位点未编辑的GluA2的AMPA受体具有Ca2 +渗透性,缺少ADAR2的运动神经元在条件性ADAR2敲除(AR2)小鼠中缓慢死亡,这是一种机械ALS模型,其中ADAR2基因靶向胆碱能神经元。此外,缺陷ARDAR2诱导的TDP-43错位类似于在AR2小鼠运动神经元的散发性ALS患者中看到的TDP-43病理学。 TDP-43的异常错位是由Ca2 +依赖性丝氨酸蛋白酶钙蛋白酶的活化引起的,该蛋白酶特异性地在C端区域切割了TDP-43,并产生了易于聚集的N端片段。值得注意的是,在ALS患者的脑和脊髓中证实了缺乏C末端的TDP-43的N末端片段。由于AMPA受体的Ca2 +渗透性或运动神经元中钙蛋白酶活性的标准化使AR2小鼠中TDP-43的亚细胞定位正常化,因此夸大的钙蛋白酶依赖性TDP-43片段可能至少在TDP-43病理学的开始。阐明由ADAR2下调引起的神经元死亡的分子级联可以为散发性ALS提供新的特异性疗法。在这篇综述中,我们总结了来自小组的关于无效GluA2 Q / R位点RNA编辑和TDP-43病理学在散发性ALS中的作用的工作,并讨论了一般ADAR2介导的无效RNA编辑的可​​能影响。本文是《 2013年RNA代谢》特刊的一部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号